INTERVENCIONES CORONARIAS en PACIENTES con FIBRILACI

Loading...

Conrad Simpfendorfer
2014-12-05

MD. FACC
Heart & Vascular Institute
Cleveland Clinc

More articles by this author

Scaffold bioabsorbibles. Estado Actual y Proyección

Roberto Botelho2014-12-05MD, PhD

Estado Actual del Cierre Percutáneo de la Orejuela Auricular Izquierda

Aníbal Damonte 2014-12-05Departamento de Cardiología IntervencionistaInstituto Cardiovascular de RosarioRosario, Argentina

Revascularización Percutánea Coronaria Aplicación de los Ultimos Avances en Latinoamérica

Hugo Londero2014-12-05Sanatorio Allende – CórdobaAgentina 

Angioplastia de Tronco Coronário Izquierdo: Perspectiva

Gilberto L. Nunes2014-12-05Hospital Divina Providencia. Porto Alegre, RSBRASIL  

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Use of DCB in Coronary Territory: Position Document of the Academic Research Consortium

The use of drug-coated balloons (DCB) is emerging as one of the most promising strategies in coronary angioplasty, particularly in clinical scenarios where avoiding...

IVUS Guided PCI: New Expansion Threshold

Intravascular ultrasound (IVUS) guided percutaneous coronary intervention (PCI) has been shown to improve clinical outcomes vs the conventional angiography guided PCI. This benefit has...

Use of Drug-Coated Balloons in Chronic Total Occlusions: The ERCTO Registry

Chronic total coronary occlusions (CTO) are still a major challenge in interventional cardiology, affecting 16%–18% of patients with coronary artery disease. While drug-eluting stents...